Philip PA - Search Results

1

Phase I study of intravenous 4-hydroxyanisole.

Rustin GJ, Stratford MR, Lamont A, Bleehen N, Philip PA, Howells N, Watfa RR, Slack JA. Rustin GJ, et al. Among authors: philip pa. Eur J Cancer. 1992;28A(8-9):1362-4. doi: 10.1016/0959-8049(92)90520-c. Eur J Cancer. 1992. PMID: 1515252 Clinical Trial.

2

Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinoma.

Philip PA, Rustin GJ, Ledermann JA, Begent RH, Newlands ES, Bagshawe KD. Philip PA, et al. Clin Oncol (R Coll Radiol). 1991 Jul;3(4):214-6. doi: 10.1016/s0936-6555(05)80742-3. Clin Oncol (R Coll Radiol). 1991. PMID: 1931762

3

In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.

Philip PA, Bagshawe KD, Searle F, Green AJ, Begent RH, Newlands ES, Rustin GJ, Adam T. Philip PA, et al. Br J Cancer. 1991 Jan;63(1):134-5. doi: 10.1038/bjc.1991.27. Br J Cancer. 1991. PMID: 1989652 Free PMC article. No abstract available.

4

Bone disease in testicular and extragonadal germ cell tumours.

Hitchins RN, Philip PA, Wignall B, Newlands ES, Begent RH, Rustin GJ, Bagshawe KD. Hitchins RN, et al. Among authors: philip pa. Br J Cancer. 1988 Dec;58(6):793-6. doi: 10.1038/bjc.1988.311. Br J Cancer. 1988. PMID: 3224081 Free PMC article.

5

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.

Philip PA, Zalupski MM, Vaitkevicius VK, Arlauskas P, Chaplen R, Heilbrun LK, Adsay V, Weaver D, Shields AF. Philip PA, et al. Cancer. 2001 Aug 1;92(3):569-77. doi: 10.1002/1097-0142(20010801)92:3<569::aid-cncr1356>3.0.co;2-d. Cancer. 2001. PMID: 11505401 Clinical Trial.

6

A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma.

Philip PA, Carmichael J, Tonkin K, Ganesan TA, Harris AL. Philip PA, et al. Eur J Cancer. 1994;30A(7):1027-9. doi: 10.1016/0959-8049(94)90137-6. Eur J Cancer. 1994. PMID: 7946568 Clinical Trial.

7

Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee.

Philip PA, Rea D, Thavasu P, Carmichael J, Stuart NS, Rockett H, Talbot DC, Ganesan T, Pettit GR, Balkwill F, et al. Philip PA, et al. J Natl Cancer Inst. 1993 Nov 17;85(22):1812-8. doi: 10.1093/jnci/85.22.1812. J Natl Cancer Inst. 1993. PMID: 8230261 Clinical Trial.

8

Phase II study of CI-958 in colorectal cancer.

Shields AF, Philip PA, LoRusso PM, Ferris AM, Zalupski MM. Shields AF, et al. Among authors: philip pa. Cancer Chemother Pharmacol. 1999;43(2):162-4. doi: 10.1007/s002800050878. Cancer Chemother Pharmacol. 1999. PMID: 9923823 Clinical Trial.

9

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.

Rougier P, Riess H, Manges R, Karasek P, Humblet Y, Barone C, Santoro A, Assadourian S, Hatteville L, Philip PA. Rougier P, et al. Among authors: philip pa. Eur J Cancer. 2013 Aug;49(12):2633-42. doi: 10.1016/j.ejca.2013.04.002. Epub 2013 Apr 30. Eur J Cancer. 2013. PMID: 23642329 Clinical Trial.

10

A phase I study on the reversal of multidrug resistance (MDR) in vivo: nifedipine plus etoposide.

Philip PA, Joel S, Monkman SC, Dolega-Ossowski E, Tonkin K, Carmichael J, Idle JR, Harris AL. Philip PA, et al. Br J Cancer. 1992 Feb;65(2):267-70. doi: 10.1038/bjc.1992.53. Br J Cancer. 1992. PMID: 1739628 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters